MNPR Financials
Monopar Therapeutics - Financial statements & key metrics
Stock Price
$70.32
Market Cap
$469.92M
EPS
$-3.96
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-15.59M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$60.29M
Total Liabilities
$5.25M
Shareholders Equity
-
Cash & Equivalents
$45.82M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-6.40M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MNPR revenue?
View MNPR's income statement for detailed revenue data.
Is MNPR profitable?
MNPR reported a loss of $15.59M in the most recent quarter.
What is MNPR market cap?
MNPR has a market capitalization of $469.92M, making it a small-cap stock.
Does MNPR have debt?
View MNPR's balance sheet for debt information.
What is MNPR cash flow?
Cash flow data is available in the full financial statements.